© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer
January 14, 2021
Examining current treatment options for brain metastases in metastatic HER2+ breast cancer and assessing the clinical and economic burden.